Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/2/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong John Bissler?

John J. Bissler

Nephrologist

Cincinnati Children's

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Cincinnati Children's

Find other employees at this company (14,172)

Background Information

Employment History

Professor

University of Tennessee


Co-Principal Investigator

National Institutes of Health


Pediatric Nephrologist

University of Cincinnati


Professor

Cincinnati Children's Hospital Medical Center


Academic Partner

Computational Medicine Center


Affiliations

TS Alliance

Director, Division of Nephrology


Operating

Board Member


The LAM Foundation

Advisory Board Member


NATIONAL ASSOCIATION OF STATE DIRECTORS OF DEVELOPMENTAL DISABILITIES

Board Member


LAM Treatment Alliance

Scientific Board of Advisors Member


LAM

Advisory Board Member


Education

M.D.

University of Cincinnati


Web References(89 Total References)


Everolimus in tuberous sclerosis complex - Phase 3 trial shows promising results - ICNApedia

icnapedia.org [cached]

Based on studies by John Bissler, MD, a nephrologist at Cincinnati Children's, the US Food and Drug Administration (FDA) earlier this year approved everolimus as the first medication to shrink non-cancerous kidney tumors that strike up to 80 percent of people with TSC.


www.bioabb.com

Based on studies by John Bissler, MD, a nephrologist at Cincinnati Childrens and co-director of the TSC clinic, the US Food and Drug Administration (FDA) earlier this year approved everolimus as the first medication to shrink non-cancerous kidney tumors that strike up to 80 percent of people with TSC.


www.eurekalert.org

Based on studies by John Bissler, MD, a nephrologist at Cincinnati Children's and co-director of the TSC clinic, the US Food and Drug Administration (FDA) earlier this year approved everolimus as the first medication to shrink non-cancerous kidney tumors that strike up to 80 percent of people with TSC.


Meet the Kidney Tumor Program Team, Cincinnati Children's Hospital Medical Center

www.cincinnatichildrens.org [cached]

Dr. Geller works closely with John J. Bissler, MD, a nephrologist at Cincinnati Children's.
Dr. Bissler was recently appointed to serve as the first committee nephrologist for the Children's Oncology Group Renal Tumor Committee. This is the national committee for the development and implementation of clinical research trials for the treatment of pediatric kidney cancer. Dr. Bissler focuses on clinical and scientific research in neoplastic growth in the kidneys, with a specific focus on tuberous sclerosis and renal angiomyolipomas.


Home | Medical News: Memphis

www.memphismedicalnews.com [cached]

Le Bonheur's John Bissler has become a leading expert on tuberous sclerosis.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory